American drugmaker Moderna said on Thursday, April 12, that it had paused its plans to build an mRNA vaccine manufacturing plant in Kenya as demand for vaccines in Africa falls.
The company said that the continent’s uptake of COVID-19 vaccines is no longer sufficient enough to support the project.
“The demand in Africa for COVID-19 vaccines has declined since the pandemic and is insufficient to support the viability of the factory planned in Kenya,” the company said in a statement.
Moderna said it…
Read more on AllAfrica.com
South Africa Today Africa – East Africa Kenya News
